Compositions and methods for targeted delivery to cells
US-2024390271-A1 · Nov 28, 2024 · US
US10117935B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10117935-B2 |
| Application number | US-201515534923-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 10, 2015 |
| Priority date | Dec 11, 2014 |
| Publication date | Nov 6, 2018 |
| Grant date | Nov 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of delivering or sequestering anesthetic agents by adsorption of such agents by porous partially fluorinated compounds which display high weight adsorption capacities.
Opening claim text (preview).
What is claimed is: 1. A method of binding an anesthetic agent comprising: contacting a gas comprising an anesthetic agent with a non-covalent organic framework comprising a compound of: wherein said compound forms a porous supramolecular structure; and adsorbing said anesthetic agent within the pores of a compound of Formula 1. 2. The method of claim 1 , further comprising delivering said anesthetic agent to a patient in need thereof. 3. The method of claim 2 , further comprising sequestering said anesthetic agent from a said patient. 4. The method of claim 3 , wherein said sequestering occurs post operatively. 5. The method of claim 3 , wherein said sequestering occurs during an operative procedure. 6. The method of claim 3 , wherein said sequestering reduces toxicity. 7. The method of claim 3 wherein said sequestering reduces post-operative stress. 8. The method of claim 1 , wherein said framework has a weight adsorption capacity of about 50% to about 75% for said anesthetic agent. 9. The method of claim 1 , wherein said framework has a weight adsorption capacity of about 60 to about 65% for said anesthetic agent. 10. The method of claim 5 , wherein said anesthetic agents comprise fluorinated anesthetics, non-fluorinated anesthetics or a combination thereof. 11. The method of claim 1 , wherein the anesthetics comprise sevoflurane, enflurane, isoflurane, methoxyflurane, desflurane, halothane, or combinations thereof.
Halogen atoms or nitro radicals · CPC title
acyclic, e.g. paraformaldehyde · CPC title
Fluorine · CPC title
by adsorption, e.g. preparative gas chromatography {(solid sorbent compositions B01J20/00, preparation of inorganic compounds or elements C01)} · CPC title
Halogenated hydrocarbons · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.